Organization
Tenri Yorozu Sodansyo Hospital
1 abstract
Abstract
ABATACEPT (CTLA4-IG) SUPPRESSES T CELL ACTIVATION AND REDUCES TH17 CELLS AS WELL AS PLASMA IL-6 IN PATIENTS WITH RHEUMATOID ARTHRITIS Org: Wakayama Medical University, Wakayama, Japan, Hyogo College of Medicine, Division of Rheumatology, Department of Internal Medicine, Nishinomiya, Japan, Graduate School of Medicine Kyoto University, Yukioka Hospital, NTT West Osaka Hospital, Osaka,